Estimation of Prolactin Level in Women with Carcinoma Breast

References

1. Mansfield C.M. A review of the etiology of breast cancer. J Nati Med Assoc.1993;85(3):217-221.
2. Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, and Weinberg RA et al. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol. 1999;210(1):96-106.
3. Hector Macias & Lindsay Hinck, Mammary Gland Development. Wiley Interdiscip Rev Dev Biol. 2012;1(4):533-557.
4. Thorner MO, Round J, Jones A, Fahmy D, Groom GV, Butcher S, Thompson K. Serum prolactin and estradiol levels at different stages of puberty. Clin Endocrinol (Oxf). 1977;7(6): 463-468.
5. Balint-peric LA, Prelevic GM. Changes in prolactin levels with the menopause: the effects of estrogen/androgen and calcitonin treatment. Gynaecol Endocrinol. 1997;11(4):275-80.
6. Sassin JF, Frantz AG, Weitzman ED, Kapen S. Human Prolactin: 24 hour pattern with increased release during sleep. Science. 1972 ;177(4055):1205-1207.
7. Clevenger C.V, Chang W.P, Ngo W, Pasha T.L, Montone K.T, Tomaszewski J.E. Expression of Prolactin and Prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am J Pathol. 1995;146(3):695-705.
8. Sakamoto K, Krempler A, Triplett AA, Zhu J, Rui H and Wagner K-U. Essential functions of the Janus Kinase 2(Jak 2) during mammary gland development and tumorigenesis. Breast Cancer Research. 2005;7(2): 3.3 DOI:10.1186/bcr
   [Google Scholar] 1125.
9. Pearson O.H, Llerena L, Molina A, and Butler T. Prolactin- dependent rat mammary cancer: a model for man? Trans. Assoc. Am. Physicians. 1969;82;225-238.
10. Hill P, Wynder E.L, Kumar H, Helman P, Rona G, and Kuno K. Prolactin level in population at risk for breast cancer. Cancer Res.1976;36(11):4102-4106.
11. Henderson BE, Gerkins V, Rosario I, Casagrande J, Pike MC. Elevated serum levels of estrogen and Prolactin in daughters of parents with breast cancer. New Engl J Med. 1975;293(16):790-795.
12. Cohen AD, Cohen Y, Maislos M, Buskila D. Prolactin serum level in patients with breast cancer. Isr Med Assoc J.2000;2(4):287-9.
13. Sheth NA,Ranadive KJ, SuraiyaJN, Sheth AR. Circulating levels of Prolactin in human breast cancer.Br J Cancer. 1975;32(2):160-167.
14. Cole EN, Sellwood RA, England PC, Griffiths K. Serum Prolactin concentrations throughout the menstrual cycle of normal women and patients with recent breast cancer. Eur J Cancer. 1977;13(7);677-684.
15. Bani I A, Williams C M, Boulter P S, Dickerson J W. Plasma lipids and Prolactin in patients with breast cancer. Br J Cancer. 1986;54(3); 439-446.
16. Korenman SG. The endocrinology of breast cancer. Cancer.1980;46(4):874-8.
17. Garas A, Trypsianis G, Kallitsaris A, Milingos S, Messinis IE. Oestradiol stimulates Prolactin secretion in women through estrogen receptors. Clin Endocrinol (oxf). 2006;65(5):638-42.
18. Hill P, Garbaczewski L, Helman P, Huskisson J, Sporangisa E, and Wynder E.L. Diet, lifestyle, and menstrual activity. Am J Clin Nutr J 1980;33(6):1192-
19. Musey VC, Collins DC, Musey PI, Martino-Saltzman D, Preedy JR. Long term effect of a first pregnancy on the secretion of Prolactin. N Engl J Med .1987;316(5):229-
20. Lissoni P, Mandala M, Giani L, Malugani F, Secondino S, Zonato S et al. Efficacy of Bromocryptine in the treatment of metastatic breast cancer and prostate cancer- related hyperprolactinaemia. Neuro Endocrinol Lett.2000;21(5):405-408.
21. Biller BM, Luciano A, Crosignani P, Molitch M, Olive D, Rebar R. Guidelines for the diagnosis and treatment of hyperprolactinaemia. J Reprod Med.1999;44(12):1075-
22. Ferriani RA, Silva de sa MF. Effect of venipuncture stress on plasma Prolactin levels. Int J Gynaecol Obstet 1985;23(6):459-62.
23. Franchimont P, Dourcy C, Legros JJ, Reuter A, Vrindts- Gevaert Y, Van Cauwenberge JR, Gaspard U. Prolactin levels during the menstrual cycle. Clin Endocrinol (Oxf)1976 Nov;5(6):643-50. PSL Saravanan et al. Estimation of Prolactin Level in Women with Carcinoma Breast Indian Journal of Clinical Anatomy and Physiology, July-September, 2017;4(3):381-385 385
24. Hammond KR, Steeinkampf MP, Boots LR, Blackwee RE. The effect of routine breast examination on serum Prolactin levels. Fertil Steril 1996;65(4):869-70.
25. Moult P. J. A, Dacie J .E, Rees L. H, Besser G.M. Prolactin pulsality in patients with Gonadal dysfunction. Clin. Endocrinol 1981;14(4):387-394.
26. Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C et al. Increased expression of Prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metal 1998;83(2):667-74.
27. Ingrid Struman, Frauke Bentzien, Hsinyu Lee, Veronique Mainfroid, Gisela D Angelo, Vincent Goffin. Opposing actions of intact and N-terminal fragments of the human Prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc. Natl. Acad. Sci USA 1999;96(4):1246-1251.
28. Germaine Fuh and James A Wells .Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J Biol Chem. 1995:270:13133-13137.
29. Bernard DJ, Maurizis JC, Chassangne J, Chollet Ph and Plagne R. Effect of Prolactin on Class II HLA antigen expression by MCF-7 cell line. Anticancer Research. 1986;6(1):79-83.
30. Favy DA, Rio P, Maurizis JC, Hizel C, Bignon YJ, Bernard-Gallon DJ. Prolactin dependent up regulation of BRCA1 expression in human breast cancer cell lines. Biochem Biophys Res Common. 1999;258(2):284-91.